Lobbying Disclosure: Mary J. Griffin & Associates for Isolyser Company Inc.
June 20, 2026
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
The Frame
This report tracks the financial influence exerted on state agencies regarding medical waste regulations and pesticide product registration between January 1, 2000, and March 31, 2000.
Potentially affected actors named in the source documents. Mention is not a position.
Isolyser Company Inc
The company engaged a firm to influence state regulatory processes.
Mary J. Griffin & Associates
The firm received payment to perform lobbying services for a client.
Last recorded activity June 20, 2026.
Next step not available in the current record.
Summary
Key Facts
- The lobbying firm Mary J. Griffin & Associates represented Isolyser Company Inc. during the period of January 1, 2000, to March 31, 2000.
- Isolyser Company Inc. paid $6,000 for lobbying services during this three-month period.
- Lobbying activities focused on the implementation of medical waste regulations at the Department of Health Services.
- Lobbying activities included addressing product registration issues at the Department of Pesticide Regulation.
Frequently Asked Questions
What was the purpose of this lobbying activity?
How much was paid for these services?
Why It Matters
This report tracks the financial influence exerted on state agencies regarding medical waste regulations and pesticide product registration between January 1, 2000, and March 31, 2000.
News Coverage
Lobbying Activity
Mary J. Griffin & Associates
on behalf of Isolyser Company Inc
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Medical Waste Regulation Focus
The lobbying activity specifically targeted the implementation phase of medical waste regulations, suggesting a critical period for industry compliance standards.
Connected Entities
Sources
www.sos.ca.gov
Analysis Score
0–100- Significance30How much this matters to a regular citizen
- Controversy10Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz5Current news / social attention level
Publisher tools